Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 study evaluating Macitentan for efficacy and safety in patients with pulmonary hypertension after left ventricular as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• OPSUMIT (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-04-01